Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Sell
7,276
-33,424
-82% -$4.96M 0.02% 353
2026
Q1
$3.79M Hold
40,700
0.07% 125
2025
Q4
$3.27M Hold
40,700
0.07% 131
2025
Q3
$3.97M Buy
+40,700
New +$3.28M 0.05% 234

Other funds holding ACLS

Ossiam's ACLS Position: Q2 2026 in Review

Ossiam reduced its Axcelis (ACLS) stake by 82% in Q2 2026, selling an estimated $4.96M and leaving 7,276 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #353.

Ossiam first reported a position in ACLS in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.97M in Q3 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Ossiam held 7,276 shares of Axcelis worth $1.38M as of Q2 2026.
  • Ossiam sold 33,424 Axcelis shares in Q2 2026, an estimated $4.96M.
  • Axcelis made up 0.02% of Ossiam's portfolio in Q2 2026, its #353 holding.
  • Ossiam first reported a position in Axcelis in Q3 2025 and has held it in 4 quarters since.
  • Ossiam's Axcelis position peaked at $3.97M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.